| 1 | A 3-MONTH RANDOMIZED CONTROLLED TRIAL OF BIMATOPROST (LUMIGAN) VERSUS TIMOLOL/DORZOLAMIDE (COS - OPT) IN PATIENTS WITH GLAUCOMA OR OCULAR HYPERTENSION A. Coleman, P. Bern-显示文摘Objective: To compare efficacy and safety of bimato-prost (Lumigan) QD vs timolol/dorzolamide (Cosopt) BID. Methods: Randomized, double-masked, multicenter 3-month clinical trial. 177 patients with glaucoma or ocular hypertension with uncontrolled intraocular pressure (IOPs between 22 and 34 mmHg) after at least 2 weeks of timolol 0.5% monotherapy | A.Coleman P.Bern-stein S.Whitcup | 2003 | 国际眼科杂志2003，3，1： | 13 |
您所在的机构暂未开通此部分的功能，请联系管理员